Further research is required to confirm or refute the BASIL findings and recommendations ; validate the BASIL survival prediction model in a separate cohort of patients with SLI ; examine the clinical and cost-effectiveness of new endovascular techniques and devices ; and compare revascularisation with primary amputation and with best medical and nursing care in those SLI patients with the poorest survival prospects .
